Guillain-Barré Syndrome in India: Population-based validation of the Brighton criteria

Vaccine

Volumn 29, Issue 52, 2011, Pages 9697-9701

  Mateen, Farrah J ^a,b   Cornblath, David R ^a   Jafari, Hamid ^c   Shinohara, Russell T ^a   Khandit, Devendra ^c   Ahuja, Bina ^c   Bahl, Sunil ^c   Sutter, Roland W ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c National Polio Surveillance Unit of India   (India)

Author keywords

Epidemiology; Guillain Barr Syndrome; India; Paralysis; Surveillance

Indexed keywords

ALBUMIN;

ACUTE DISEASE; ADOLESCENT; AREFLEXIA; ARTICLE; BRIGHTON CRITERIA; BULBAR PARALYSIS; CALCULATION; CASE FINDING; CELL COUNT; CEREBROSPINAL FLUID; CHILD; CHILDHOOD DISEASE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CRANIAL NERVE PARALYSIS; DIAPHRAGM PARALYSIS; DISABILITY SEVERITY; FEMALE; FLACCID PARALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; HYPOREFLEXIA; INDIA; LEG DISEASE; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MUSCLE HYPOTONIA; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SCHOOL CHILD; SENSITIVITY ANALYSIS; VALIDATION STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; COHORT STUDIES; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INDIA; MALE; SENSITIVITY AND SPECIFICITY;

EID: 82555170272     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.123     Document Type: Article

References (21)

1. McGrogan A., Madle G.C., Seaman H.E., de Vries C.S. The epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology 2009, 32(2):150-163.
2. Schonberger L.B., Bregman D.J., Sullivan-Bolyai J.Z., Keenlyside R.A., Ziegler D.W., Retailliau H.F., et al. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States 1976-7. Am J Epidemiol 1979, 110(11):105-123.
3. Keenlyside R.A., Schonberger L.B., Bregman D.J., Bolyai J.Z. Fatal Guillain-Barré syndrome after the national immunization program. Neurology 1980, 30(9):929-933.
4. Liang X., Li L., Liu D., Li K.L., Wu W.D., Zhu B.P., et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med 2011, 364(7):638-647.
5. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990, 27:S21-S24.
6. Hughes R.A., Cornblath D.R. Guillain-Barré syndrome. Lancet 2005, 366(4997):1653-1666.
7. Sejvar J.J., Kohl K.S., Gidudu J., Amato A., Bakshi N., Baxter R., et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011, 29(3):599-612.
8. Acute onset flaccid paralysis 1993, World Health Organization, WHO Press, p. 24-6.
9. Kalra V., Sankhyan N., Sharma S., Gulati S., Choudhry R., Dhawan B. Outcome in childhood Guillain-Barré Syndrome. Ind J Pediatr 2009, 76(8):795-799.
10. Peter J.V., Gnanamuthu C., Cherian A.M., Prebhakar S. Outcomes in the Guillain-Barré syndrome: the role of steroids. J Assoc Physicians India 1996, 44(3):172-174.
11. Ho T.W., Mishu B., Li Y., Gao C.Y., Cornblath D.R., Griffin J.W., et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995, 118(Pt 3):597-605.
12. Nachamkin I., Arzate Barbosa P., Ung H., Lobato C., Gonzalez Rivera A., Rodriguez P., et al. Patterns of Guillain-Barré syndrome in children results from a Mexican population. Neurology 2007, 69(15):1665-1671.
13. Islam Z., Jacobs B.C., van Belkum A., Mohammad Q.D., Islam M.B., Herbrink P., et al. Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh. Neurology 2010, 74(7):581-587.
14. Francis P.T. Surveillance of acute flaccid paralysis in India. Lancet 2007, 369(9582):1322-1323.
15. National Polio Surveillance Project. National Expert Review Committee (ERC). [last accessed 20.05.11]. http://www.npspindia.org/Expert.asp.
16. Hughes R.A., Swan A.V., Raphael J.C., Annane D., van Koningsveld R., van Doorn P.A. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 2007, 130(pt 9):2245-2257.
17. Hadden R.D., Cornblath D.R., Hughes R.C., Zielasek J., Hartung H.P., Toyka K.V., et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 1998, 44(5):780-788.
18. Chhuttani P.N., Chawla L.S., Chugh K.S., Singh H. Landry-Guillain-Barré-Strohl syndrome in India. J Neurol Sci 1968, 7(3):581-592.
19. Sarada C., Tharakan J.K., Nair M. Guillain-Barré syndrome. A prospective clinical study in 25 children and comparison with adults. Ann Trop Paediatr 1994, 14(4):281-286.
20. Drenthen J., Yuki N., Meulstee J., Maathuis E.M., van Doorn P.A., Visser G.H., et al. Guillain-Barré syndrome subtypes related to Campylobacter infection. J Neurol Neurosurg Psychiatry 2011, 82(3):300-305.
21. Choe Y.J., Cho H., Bae G., Lee J. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition. Vaccine 2011, 29(11):2066-2070.